Sapiens International (SPNS) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,907.04% |
Hycroft Mining (HYMC) | 1,004.42% |
Cidara Therapeutics (CDTX) | 714.68% |
Celcuity LLC (CELC) | 676.17% |
Terns Pharmaceuticals (TERN) | 651.42% |
Sandisk (SNDK) | 613.29% |
TMC the metals (TMC) | 568.42% |
GRAIL, LLC (GRAL) | 415.49% |
Cogent Biosciences (COGT) | 402.91% |
Planet Labs PBC (PL) | 396.82% |
Olema Pharmaceuticals (OLMA) | 363.68% |
Aris Mining (ARMN) | 359.72% |
Aura Minerals Inc Common Shares (AUGO) | 358.23% |
ViaSat (VSAT) | 299.43% |
Opendoor Technologies (OPEN) | 286.46% |
DRDGOLD Limited ADR (DRD) | 285.81% |
Centrus Energy (LEU) | 285.34% |
Arrowhead Pharmaceuticals (ARWR) | 270.17% |
Ondas (ONDS) | 265.2% |
New Gold (NGD) | 261.75% |
Nuvation Bio (NUVB) | 255.22% |
Praxis Precision Medicines (PRAX) | 253.53% |
MP Materials (MP) | 244.1% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
